NCT03802864

Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Weill Medical College of Cornell University · Academic / Other
• Sex: Male
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic) for men undergoing testicular sperm extraction.

Conditions

• Male Infertility

Interventions

Type	Name	Description
DRUG	Liposomal Bupivacaine	After surgical sperm retrieval, the wound will be injected with liposomal bupivacaine (266 mg) mixed with standard bupivacaine (bupivacaine hydrochloride 50mg) for post-operative pain relief.
DRUG	Standard Bupivacaine	After surgical sperm retrieval, the wound will be injected only with standard bupivacaine (bupivacaine hydrochloride 100mg) for post-operative pain relief.

Timeline

• Start date: 2019-02-04
• Primary completion: 2020-01-30
• Completion: 2020-01-30
• First posted: 2019-01-14
• Last updated: 2020-12-17
• Results posted: 2020-12-17

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study